Skip to main content

Insights

Independent analysis of company developments, industry trends, and capital markets, with a focus on undercovered public companies. We examine what changed, why it matters, and the implications for investors.

Topics

88 insights

Researcher reviewing skeletal CT scans showing abnormal bone formation, with capsules and a bone model on a clinical research desk.Biotechnology & Healthcare

Mirum’s Atebrioz Approval Shows Why a Missed Primary Endpoint Does Not Always End a Drug Program

FDA approved Atebrioz for fibrodysplasia ossificans progressiva after a 63-patient trial in which a closely watched lesion-incidence endpoint failed to reach conventional statistical significance. The approval highlights the importance of effect size, endpoint selection and totality of evidence, but for Mirum the commercial question may be harder than the regulatory one.

Alliance Equity ResearchSeptember 27, 20269 min read
Read article
Microscope, sample vials, capsules, and neuroscience imaging displayed in a modern biotechnology laboratory.Biotechnology & Healthcare

NeuroSense’s PrimeC Has Built a Stronger ALS Data Package, but Financing Is Now the Critical Variable

NeuroSense Therapeutics is targeting a Canadian filing for PrimeC in December while exploring a potentially smaller U.S. pivotal program and an accelerated-approval pathway. The clinical dataset has strengthened materially, but with only $0.23 million of cash reported at June 30, the investment case increasingly depends on whether the company can convert its regulatory progress into financing, partnership support, or a more capital-efficient route to approval.

Alliance Equity ResearchSeptember 27, 20268 min read
Read article
Jet engine turbine blades, ceramic-coated components, mineral samples, and materials-testing equipment arranged in an aerospace research laboratory.Mining & Critical Minerals

Critical Minerals Are Forcing Aerospace to Rethink Materials, but Substitution Has Limits

Aerospace suppliers are testing alternatives to rare-earth-dependent coatings as China’s dominance in critical-mineral production and processing keeps supply-chain risk elevated. Substitution can reduce exposure in selected applications, but it does not solve the wider problem of concentrated refining and component supply.

Alliance Equity ResearchSeptember 27, 20267 min read
Read article
Two excavators in a dusty landscape digging among oversized graphics cardsMarket Commentary

AI Gold Rush: Inside the Multi-Trillion-Dollar AI Arms Race With No Clear Payoff (Yet)

With tech giants pouring billions into chips, data centers, and power grids despite unclear returns. Is the payoff coming, or is this a high-stakes gamble?

Alliance Equity ResearchAugust 6, 202517 min read
Read article